Tevogen Bio Holdings Inc.
General ticker "TVGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $134.1M (TTM average)
Tevogen Bio Holdings Inc. does not follow the US Stock Market performance with the rate: -35.6%.
Estimated limits based on current volatility of 9.7%: low 9.47$, high 11.51$
Factors to consider:
- Total employees count: 3 as of 2021
- Current price 47.2% below estimated low
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [25.76$, 104.66$]
- 2025-12-31 to 2026-12-31 estimated range: [18.19$, 76.02$]
Financial Metrics affecting the TVGN estimates:
- Negative: with PPE of -21.4 at the end of fiscal year the price was very high
- Negative: Operating cash flow per share per price, % of -8.16 <= 0.02
- Negative: negative Operating income
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -192.80 <= 19.44
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.63
- Positive: Inventory ratio change, % of 0 <= 0
Short-term TVGN quotes
Long-term TVGN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $0.95MM | $8.84MM | $53.56MM |
| Operating Income | $-0.95MM | $-8.84MM | $-53.56MM |
| Non-Operating Income | $5.36MM | $-51.63MM | $39.84MM |
| Interest Expense | $0.00MM | $0.26MM | $0.18MM |
| R&D Expense | $0.00MM | $4.40MM | $31.03MM |
| Income(Loss) | $4.41MM | $-60.48MM | $-13.73MM |
| Profit(Loss)* | $30.86MM | $-60.48MM | $-10.11MM |
| Stockholders Equity | $-14.78MM | $-94.43MM | $-6.67MM |
| Assets | $357.14MM | $5.51MM | $3.46MM |
| Operating Cash Flow | $-0.22MM | $-8.17MM | $-12.00MM |
| Capital expenditure | $0.48MM | $0.13MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-0.13MM | $0.00MM |
| Financing Cash Flow | $0.00MM | $3.87MM | $12.23MM |
| Earnings Per Share** | $12.86 | $-18.28 | $-3.45 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.